Fig. 3From: Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysisPooled estimates of the network meta-analysis. Odds ratios (95% confidence intervals) for objective response rates (upper triangle) and grade ≥ 3 adverse events (lower triangle). Data in each cell are the comparison of row-defining treatment versus column-defining treatment. Significant results are shown in bold (BSC = best supportive care, ST = systemic treatment, pfu = plaque-forming units)Back to article page